Moderna's stock sinks toward record losing streak on COVID-vaccine concerns
Moderna's stock was in danger of breaking its record for consecutive losses as investors expressed increasing caution over slowing sales of COVID vaccines.
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna's stock was in danger of breaking its record for consecutive losses as investors expressed increasing caution over slowing sales of COVID vaccines.
Roughly half of children are noninfectious 3 days after a positive COVID-19 test, independent of vaccination status.
Once buoyed by demand for COVID-19 vaccines and treatments, the biotech industry is experiencing a sobering leveling out
Combination meningococcal vaccine may boost uptake among adolescents, researchers say.
By Stephen Nakrosis Pfizer said the Food and Drug Administration approved Penbraya, a vaccine preventing the five most common serogroups causing...